Pediatrics
Scientists at the Department of Pediatrics, Guangzhou Development District Hospital, have made significant breakthroughs in understanding the role of microRNA-3164 (miR-3164) in regulating neutrophil extracellular traps (NETs) and its potential as a therapeutic target for asthma treatment. According to their study, published in the European Journal of Medical Research, miR-3164
Asthma
Researchers at Huazhong University of Science and Technology Tongji Medical College have identified SERPINB10 as a potential therapeutic target for airway neutrophilia in asthma. Through a series of experiments involving mouse models and human bronchial epithelial cells, the team found that SERPINB10 promotes IL-1b and IL-6 expression by upregulating NF-kB
Stem cells
A new study published in Cytotechnology has shed light on the potential of mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) in treating asthma. Researchers from the Catholic University of Korea found that SHEDs can significantly reduce airway inflammation and hyperresponsiveness in a mouse model of allergic asthma.
Bronchiectasis
Bronchiectasis is a chronic inflammatory airway disease characterized by impaired mucociliary clearance, persistent infection, and progressive structural lung damage. While inflammation is central to disease activity and progression, targeted anti-inflammatory treatments have been limited. Researchers from the Mayo Clinic have conducted a review to explore key inflammation patterns, biomarkers, and
Asthma
Researchers at Ningxia Medical University have conducted a study on the effectiveness of biological agents in treating severe asthma. According to the study, asthma is a complex inflammatory condition that can be categorized into two main types: type 2 inflammatory asthma and non-type 2 inflammatory asthma. Type 2 inflammation is
